Share Name Share Symbol Market Type
Ligand Pharmaceuticals Incorporated NASDAQ:LGND NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +$0.00 +0.00% $221.09 $220.55 $228.00 - - - 0 07:05:03

Ligand, Janssen Enter R&D Deal

11/07/2018 10:48pm

Dow Jones News

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Historical Stock Chart

1 Month : From Jun 2018 to Jul 2018

Click Here for more Ligand Pharmaceuticals Incorporated Charts.
   Micah Maidenberg 

Subsidiaries of Ligand Pharmaceutical Inc. (LGND) and Johnson & Johnson (JNJ) have entered into a research-and-development agreement focused on a "transgenic chicken platform" aimed at generating and discovering antibodies for humans, according to a securities filing.

Ligand's company Crystal Bioscience Inc., and Janssen Research & Development LLC, which is part of the Janssen Pharmaceutical Cos. of Johnson & Johnson, agreed to work together on Ligand's development of the platform, the filing said.

Under the deal, Ligand will be able to earn milestone payments contingent on various deliverables and will be able to sell the platform to others in the market.


Write to Micah Maidenberg at


(END) Dow Jones Newswires

July 11, 2018 17:33 ET (21:33 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Ligand Pharmaceuticals Incorporated Chart

1 Year Ligand Pharmaceuticals Incorporated Chart

1 Month Ligand Pharmaceuticals Incorporated Chart

1 Month Ligand Pharmaceuticals Incorporated Chart
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20180716 08:11:00